HM

Hukam Malik Chand

Director Director DIN 01199438
DIN 01199438 First appointment Apr 2003 Primary industry General Business
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 0 active board seats
Past companies 1 historical roles
Total affiliations 1 Since Apr 2003
Shareholding value Locked Premium profile

About Hukam Malik Chand

Data last updated:

Hukam Malik Chand has 23 years in corporate governance. Formerly with 1 company, such as Symbiosis Pharmaceuticals Private Limited. Engaged in General Business. Contributes to corporate operations.

DIN 01199438
Primary Designation Director
First Appointment 04 Apr 2003
Oldest Company Age Not Provided

Current companies

No current companies available.

Previous companies

CompanyDesignationAppointmentFoundedStatus
Director04 Apr 20032003Active

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Symbiosis Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Hukam Malik Chand

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Hukam Malik Chand

Hukam Malik Chand has 23 years in corporate governance. Formerly with 1 company, such as Symbiosis Pharmaceuticals Private Limited. Engaged in General Business. Contributes to corporate operations.

Hukam Malik Chand is associated with 0 companies as a director.

Hukam Malik Chand has expertise in General Business.

Hukam Malik Chand has 23 years in corporate governance.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available